tirzepatide novo nordisk FDA confirms shortage is still over, gives compounders a grace period Novo Nordisk filed a lawsuit

LactoSpore (2 Billion CFUs, Bacillus Coagulans, MTCC 5856) is a shelf-stable probiotics.* It produces lactic acid, which supports regulating the bad bacteria and helps colonize the good bacteria to maintain a healthy gut and helps balance intestinal flora.*

Everything is included for one low price

Once you reach effective dose, weight loss continues at 1-2 pounds weekly as long as calorie deficit persists

One study that Al-Aly helped conduct and published in Nature Medicine in early 2025 compared the effects of GLP-1 medications to other types of treatment in dozens of health outcomes

doi:10.1007/s00125-019-4934-x

In the SURMOUNT-5 head-to-head trial ( N Engl J Med , May 2025), tirzepatide produced 20.2% average weight loss compared to 13.7% with semaglutide over 72 weeks a 47% greater relative reduction